PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34500784-0	2021	Anti-Inflammatory Effects of 6-Methylcoumarin in LPS-Stimulated RAW 264.7 Macrophages via Regulation of MAPK and NF-kappaB Signaling Pathways.	6-methylcoumarin	29-45	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	113-122	
34500784-7	2021	Mechanistic studies revealed that 6-MC reduced the phosphorylation of the mitogen-activated protein kinase (MAPK) family and IkappaBalpha in the MAPK and nuclear factor-kappa B (NF-kappaB) pathways, respectively.	6-methylcoumarin	34-38	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	154-176	
34500784-7	2021	Mechanistic studies revealed that 6-MC reduced the phosphorylation of the mitogen-activated protein kinase (MAPK) family and IkappaBalpha in the MAPK and nuclear factor-kappa B (NF-kappaB) pathways, respectively.	6-methylcoumarin	34-38	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	178-187	
34500784-8	2021	These results suggest that 6-MC is a potential therapeutic agent for inflammatory diseases that inhibits inflammation via the MAPK and NF-kappaB pathways.	6-methylcoumarin	27-31	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	135-144